RevOpsis Therapeutics, Inc.
Biotechnology company · Springfield, Illinois, United States
RevOpsis Therapeutics, Inc. is a biotechnology company headquartered in Springfield, Illinois, United States. Its earliest recorded incorporation is in 2022. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $1.9 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $575,000 sold in a notice filed in 2024.
RevOpsis Therapeutics at a glance
What does RevOpsis Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $1.9 million in total (2024). NIH funding came from the National Eye Institute.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $575,000 sold (2024).
Frequently asked questions about RevOpsis Therapeutics
Where is RevOpsis Therapeutics headquartered?
RevOpsis Therapeutics, Inc. is headquartered in Springfield, Illinois, United States.
What does RevOpsis Therapeutics do?
RevOpsis Therapeutics, Inc. is a biotechnology company.
When was RevOpsis Therapeutics founded?
The earliest incorporation on record for RevOpsis Therapeutics, Inc. is in 2022, according to public company registers.
Similar companies
- Jericho Sciences, LLCSpringfield, Missouri, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences